Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Akouos"


2 mentions found


Gene therapy has allowed several children born with inherited deafness to hear. Globally, 34 million children have deafness or hearing loss, and genes are responsible for up to 60% of cases. Hereditary deafness is the latest condition scientists are targeting with gene therapy, which is already approved to treat illnesses such as sickle cell disease and severe hemophilia. Also, some people consider gene therapy for deafness ethically problematic. "This is real proof showing gene therapy is working,” Chen said.
Persons: , Zheng, Yi Chen, Dr, Yilai Shu, Chen, Eli Lilly, Akouos, he's, John Germiller, ” Germiller, , Lawrence Lustig, Teresa Blankmeyer Burke, ” Chen Organizations: Children's Hospital of Philadelphia, Fudan University, Shanghai Refreshgene Therapeutics, Regeneron Pharmaceuticals, Decibel Therapeutics, Columbia, Gallaudet University, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: China, Shanghai, Philadelphia, Spain
Oct 18 (Reuters) - Drugmaker Eli Lilly and Co (LLY.N) will acquire genetic medicine developer Akouos Inc (AKUS.O) in a cash deal worth about $487 million. Lilly will also pay Akouos' shareholders an additional amount of about $610 million contingent on certain events related to its trials. Register now for FREE unlimited access to Reuters.com RegisterReporting by Leroy Leo in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
Total: 2